Biontech Se Stock Technical Analysis
| BNTX Stock | USD 113.75 3.02 2.59% |
As of the 1st of February, BioNTech shows the Risk Adjusted Performance of 0.0466, downside deviation of 2.26, and Mean Deviation of 1.65. BioNTech SE technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
BioNTech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as BioNTech, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to BioNTechBioNTech's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.BioNTech Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 140.42 | Strong Buy | 21 | Odds |
Most BioNTech analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand BioNTech stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of BioNTech SE, talking to its executives and customers, or listening to BioNTech conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioNTech. Projected growth potential of BioNTech fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive BioNTech assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.43) | Earnings Share (2.80) | Revenue Per Share | Quarterly Revenue Growth 0.22 | Return On Assets |
The market value of BioNTech SE is measured differently than its book value, which is the value of BioNTech that is recorded on the company's balance sheet. Investors also form their own opinion of BioNTech's value that differs from its market value or its book value, called intrinsic value, which is BioNTech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioNTech's market value can be influenced by many factors that don't directly affect BioNTech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between BioNTech's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding BioNTech should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, BioNTech's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
BioNTech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioNTech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioNTech.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in BioNTech on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding BioNTech SE or generate 0.0% return on investment in BioNTech over 90 days. BioNTech is related to or competes with Incyte, Genmab AS, United Therapeutics, Teva Pharma, DexCom, Natera, and Koninklijke Philips. BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseas... More
BioNTech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioNTech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioNTech SE upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.26 | |||
| Information Ratio | 0.0367 | |||
| Maximum Drawdown | 14.45 | |||
| Value At Risk | (3.16) | |||
| Potential Upside | 3.28 |
BioNTech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioNTech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioNTech's standard deviation. In reality, there are many statistical measures that can use BioNTech historical prices to predict the future BioNTech's volatility.| Risk Adjusted Performance | 0.0466 | |||
| Jensen Alpha | 0.0718 | |||
| Total Risk Alpha | 0.0058 | |||
| Sortino Ratio | 0.0406 | |||
| Treynor Ratio | 0.0809 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of BioNTech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
BioNTech February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0466 | |||
| Market Risk Adjusted Performance | 0.0909 | |||
| Mean Deviation | 1.65 | |||
| Semi Deviation | 2.12 | |||
| Downside Deviation | 2.26 | |||
| Coefficient Of Variation | 1829.45 | |||
| Standard Deviation | 2.5 | |||
| Variance | 6.23 | |||
| Information Ratio | 0.0367 | |||
| Jensen Alpha | 0.0718 | |||
| Total Risk Alpha | 0.0058 | |||
| Sortino Ratio | 0.0406 | |||
| Treynor Ratio | 0.0809 | |||
| Maximum Drawdown | 14.45 | |||
| Value At Risk | (3.16) | |||
| Potential Upside | 3.28 | |||
| Downside Variance | 5.09 | |||
| Semi Variance | 4.5 | |||
| Expected Short fall | (1.78) | |||
| Skewness | 1.09 | |||
| Kurtosis | 7.23 |
BioNTech SE Backtested Returns
At this stage we consider BioNTech Stock to be very steady. BioNTech SE secures Sharpe Ratio (or Efficiency) of 0.0692, which signifies that the company had a 0.0692 % return per unit of risk over the last 3 months. We have found thirty technical indicators for BioNTech SE, which you can use to evaluate the volatility of the firm. Please confirm BioNTech's Downside Deviation of 2.26, mean deviation of 1.65, and Risk Adjusted Performance of 0.0466 to double-check if the risk estimate we provide is consistent with the expected return of 0.18%. BioNTech has a performance score of 5 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.56, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BioNTech will likely underperform. BioNTech SE right now shows a risk of 2.56%. Please confirm BioNTech SE maximum drawdown, as well as the relationship between the skewness and day typical price , to decide if BioNTech SE will be following its price patterns.
Auto-correlation | -0.76 |
Almost perfect reverse predictability
BioNTech SE has almost perfect reverse predictability. Overlapping area represents the amount of predictability between BioNTech time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioNTech SE price movement. The serial correlation of -0.76 indicates that around 76.0% of current BioNTech price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.76 | |
| Spearman Rank Test | -0.81 | |
| Residual Average | 0.0 | |
| Price Variance | 89.28 |
BioNTech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
BioNTech SE Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of BioNTech SE volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About BioNTech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of BioNTech SE on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of BioNTech SE based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on BioNTech SE price pattern first instead of the macroeconomic environment surrounding BioNTech SE. By analyzing BioNTech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of BioNTech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to BioNTech specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2025 | 2026 (projected) | Dividend Yield | 0.0123 | 0.011 | Price To Sales Ratio | 10.92 | 10.38 |
BioNTech February 1, 2026 Technical Indicators
Most technical analysis of BioNTech help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for BioNTech from various momentum indicators to cycle indicators. When you analyze BioNTech charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0466 | |||
| Market Risk Adjusted Performance | 0.0909 | |||
| Mean Deviation | 1.65 | |||
| Semi Deviation | 2.12 | |||
| Downside Deviation | 2.26 | |||
| Coefficient Of Variation | 1829.45 | |||
| Standard Deviation | 2.5 | |||
| Variance | 6.23 | |||
| Information Ratio | 0.0367 | |||
| Jensen Alpha | 0.0718 | |||
| Total Risk Alpha | 0.0058 | |||
| Sortino Ratio | 0.0406 | |||
| Treynor Ratio | 0.0809 | |||
| Maximum Drawdown | 14.45 | |||
| Value At Risk | (3.16) | |||
| Potential Upside | 3.28 | |||
| Downside Variance | 5.09 | |||
| Semi Variance | 4.5 | |||
| Expected Short fall | (1.78) | |||
| Skewness | 1.09 | |||
| Kurtosis | 7.23 |
BioNTech February 1, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as BioNTech stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.03 | ||
| Daily Balance Of Power | (0.79) | ||
| Rate Of Daily Change | 0.97 | ||
| Day Median Price | 115.07 | ||
| Day Typical Price | 114.63 | ||
| Price Action Indicator | (2.82) | ||
| Market Facilitation Index | 3.81 |
Additional Tools for BioNTech Stock Analysis
When running BioNTech's price analysis, check to measure BioNTech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioNTech is operating at the current time. Most of BioNTech's value examination focuses on studying past and present price action to predict the probability of BioNTech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioNTech's price. Additionally, you may evaluate how the addition of BioNTech to your portfolios can decrease your overall portfolio volatility.